Archive — US — techcrunch
OpenEvidence, the ChatGPT for doctors, raises $200M at $6B valuation
OpenEvidence, likened to ChatGPT for medicine, has raised $200 million at a $6 billion valuation, following a previous $210 million round. The platform, which aids doctors by quickly providing medical knowledge, has seen substantial growth in consultations. This funding round was led by Google Ventures with participation from several significant investors.
Key points
- OpenEvidence raised $200 million at a $6 billion valuation.
- The company had previously raised $210 million at a $3.5 billion valuation three months ago.
- The platform is designed for confirmed medical professionals and provides quick access to medical knowledge.
- OpenEvidence’s consultations have nearly doubled to 15 million per month since July 2023.
- Investors included Google Ventures, Sequoia Capital, and Blackstone among others.
Why it matters
- There is a growing trend in AI applications specifically for healthcare, with startups focusing on enhancing medical knowledge access.
- The investment in OpenEvidence reflects the increasing confidence in AI's role in transforming medical practices and patient treatment.
- Historically, there has been skepticism about AI in healthcare, but recent trends show a shift towards acceptance as efficiency and accuracy improve.
OpenEvidence's significant funding and rapid growth underscore the strong demand for AI tools in healthcare, a trend that is likely to continue influencing the industry through 2025.